Complete Filing Data
TScan Therapeutics, Inc. reported Stockholders Equity of $123.12 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TScan Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$129.8M | -$127.5M | -$89.2M | -$66.2M | -$48.6M | -$26.1M |
| Research And Development Expense | $114.2M | $107.4M | $88.2M | $59.8M | $45.0M | $20.6M |
| Operating Income Loss | -$135.8M | -$134.8M | -$93.5M | -$66.6M | -$48.6M | -$26.2M |
| Operating Expenses | $146.1M | $137.6M | $114.5M | $80.2M | $58.8M | $27.3M |
| General And Administrative Expense | $32.0M | $30.3M | $26.4M | $20.4M | $13.8M | $6.7M |
| Revenue From Contract With Customer Excluding Assessed Tax | $10.3M | $2.8M | $21.0M | $13.5M | $10.1M | $1.1M |
| Other Nonoperating Income Expense | $6.0M | $7.3M | $4.2M | $415.0K | $16.0K | |
| Deferred Revenue Current | $2.6M | $11.7M | $10.1M | $3.9M | $11.4M | $10.6M |
| Interest Expense | $2.8M | $3.7M | $3.8M | $1.2M | ||
| Deferred Revenue Noncurrent | $1.2M | $5.6M | $1.5M | $8.8M | ||
| Noncash Interest Expense On Notes Payable | $757.0K | $260.0K | ||||
| Comprehensive Income Net Of Tax | -$129.8M | -$127.4M | -$89.2M | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$51.0K | $51.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$35.7M | -$37.0M | -$34.1M | -$29.9M | -$31.7M | -$30.1M | -$23.0M | -$24.0M | -$22.6M | -$16.2M | -$15.1M | -$16.2M | -$15.8M | -$10.7M | -$7.9M | -$7.2M | -$5.6M |
| Research And Development Expense | $31.7M | $32.6M | $29.8M | $26.3M | $26.9M | $24.9M | $22.7M | $21.2M | $21.8M | $15.0M | $14.5M | $14.7M | $14.2M | $10.8M | $7.3M | $5.8M | $4.5M |
| Operating Income Loss | -$37.1M | -$38.7M | -$36.3M | -$32.6M | -$34.1M | -$31.4M | -$24.7M | -$24.6M | -$22.7M | -$16.6M | -$15.2M | -$16.2M | -$15.8M | -$10.7M | -$7.9M | -$7.2M | -$5.6M |
| Operating Expenses | $39.6M | $41.7M | $38.4M | $33.7M | $34.7M | $31.9M | $28.6M | $27.8M | $29.5M | $19.9M | $19.3M | $19.2M | $18.3M | $13.5M | $9.9M | $7.5M | $5.6M |
| General And Administrative Expense | $7.9M | $9.1M | $8.6M | $7.4M | $7.8M | $7.1M | $5.9M | $6.5M | $7.8M | $4.9M | $4.8M | $4.5M | $4.0M | $2.7M | $2.6M | $1.6M | $1.1M |
| Revenue From Contract With Customer Excluding Assessed Tax | $2.5M | $3.1M | $2.2M | $1.0M | $536.0K | $566.0K | $3.9M | $3.1M | $6.8M | $3.4M | $4.1M | $3.0M | $2.4M | $2.8M | $2.0M | $290.0K | |
| Other Nonoperating Income Expense | $1.3M | $1.7M | $2.1M | $2.7M | $2.5M | $1.2M | $1.8M | $565.0K | $180.0K | $333.0K | $149.0K | $7.0K | |||||
| Deferred Revenue Current | $5.2M | $7.7M | $10.3M | $9.9M | $10.7M | $10.4M | $15.2M | $19.2M | $5.9M | $8.2M | $10.9M | $12.0M | $11.7M | ||||
| Interest Expense | $699.0K | $689.0K | $679.0K | $958.0K | $952.0K | $959.0K | $982.0K | $969.0K | $956.0K | $201.0K | |||||||
| Deferred Revenue Noncurrent | $501.0K | $3.7M | $4.0M | $4.8M | $7.8M | $7.6M | $0.00 | $0.00 | $0.00 | $2.8M | $4.6M | ||||||
| Noncash Interest Expense On Notes Payable | $110.0K | $199.0K | $214.0K | ||||||||||||||
| Comprehensive Income Net Of Tax | -$35.7M | -$37.0M | -$34.2M | -$29.9M | -$31.7M | -$30.1M | |||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $6.0K | -$55.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $123.1M | $241.0M | $150.9M | $99.4M | $160.8M | -$42.5M | -$17.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $157.4M | $183.7M | $138.4M | $125.1M | $166.4M | $35.4M | $42.4M |
| Restricted Cash Noncurrent | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $595.0K | |
| Cash And Cash Equivalents At Carrying Value | $152.4M | $178.7M | $133.4M | $120.0M | $161.4M | $34.8M | |
| Operating Lease Right Of Use Asset | $57.7M | $64.4M | $63.5M | $59.1M | $5.5M | $6.9M | |
| Retained Earnings Accumulated Deficit | -$504.9M | -$375.1M | -$247.6M | -$158.4M | -$92.2M | -$43.5M | |
| Property Plant And Equipment Net | $8.7M | $7.2M | $7.7M | $10.1M | $11.8M | $5.7M | |
| Prepaid Expense And Other Assets Current | $4.8M | $2.6M | $2.2M | $4.1M | $4.2M | $1.7M | |
| Operating Lease Liability Noncurrent | $54.4M | $60.7M | $59.1M | $53.0M | $4.4M | $6.0M | |
| Operating Lease Liability Current | $7.2M | $4.6M | $3.2M | $3.7M | $1.7M | $1.4M | |
| Liabilities Current | $18.7M | $36.0M | $29.8M | $17.3M | $21.3M | $17.4M | |
| Liabilities And Stockholders Equity | $228.8M | $371.1M | $272.1M | $199.1M | $188.1M | $49.7M | |
| Liabilities | $105.7M | $130.1M | $121.3M | $99.7M | $27.3M | $32.5M | |
| Deposits Assets Noncurrent | $101.0K | $1.8M | $1.6M | $725.0K | $166.0K | $166.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$26.3M | $45.3M | $13.3M | -$41.4M | $131.1M | -$7.0M | |
| Assets Current | $157.2M | $292.7M | $194.2M | $124.1M | $165.7M | $36.4M | |
| Assets | $228.8M | $371.1M | $272.1M | $199.1M | $188.1M | $49.7M | |
| Additional Paid In Capital Common Stock | $628.0M | $616.0M | $398.5M | $257.8M | $252.9M | $1.1M | |
| Accrued Liabilities And Other Liabilities | $7.7M | $15.4M | $10.7M | $6.8M | $6.5M | $2.5M | |
| Accounts Payable Current | $1.2M | $4.3M | $2.4M | $2.9M | $1.8M | $2.9M | |
| Other Liabilities Noncurrent | $135.0K | $49.0K | $97.0K | $238.0K | |||
| Long Term Debt Noncurrent | $32.5M | $32.1M | $26.7M | $29.3M | |||
| Marketable Securities Current | $111.4M | $58.7M | |||||
| Accretion Of Marketable Securities | -$2.4M | -$3.9M | -$1.1M | ||||
| Preferred Stock Value | $0.00 | ||||||
| Long Term Debt Current | $3.3M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $51.0K | ||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $6.1M | $6.2M | $53.5M | $3.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $144.0M | $176.7M | $210.2M | $229.1M | $255.2M | $123.0M | $169.0M | $190.6M | $78.0M | $116.7M | $131.7M | $145.7M | $174.1M | -$60.0M | -$49.9M | -$34.8M | -$27.8M | -$22.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $174.5M | $174.4M | $159.1M | $138.1M | $247.2M | $145.5M | $160.2M | $213.9M | $100.6M | $142.3M | $130.6M | $145.9M | $182.9M | $106.8M | $122.1M | $44.1M | $51.2M | ||
| Restricted Cash Noncurrent | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $595.0K | $595.0K | $595.0K | ||||
| Cash And Cash Equivalents At Carrying Value | $169.5M | $169.4M | $154.1M | $133.1M | $242.2M | $140.5M | $155.2M | $208.8M | $95.6M | $137.3M | $125.6M | $140.8M | $182.3M | $106.2M | $121.5M | ||||
| Operating Lease Right Of Use Asset | $59.4M | $61.1M | $62.7M | $59.6M | $60.9M | $62.2M | $58.5M | $59.8M | $57.9M | $4.4M | $4.8M | $5.1M | $5.8M | $6.2M | |||||
| Retained Earnings Accumulated Deficit | -$481.9M | -$446.2M | -$409.2M | -$339.3M | -$309.4M | -$277.7M | -$228.0M | -$205.0M | -$180.9M | -$139.7M | -$123.4M | -$108.3M | -$78.0M | -$62.1M | |||||
| Property Plant And Equipment Net | $9.3M | $9.5M | $8.4M | $7.5M | $7.6M | $7.2M | $8.6M | $8.2M | $9.0M | $10.3M | $10.8M | $10.7M | $11.3M | $10.5M | |||||
| Prepaid Expense And Other Assets Current | $3.7M | $3.1M | $3.1M | $3.0M | $1.9M | $1.9M | $2.1M | $1.5M | $5.3M | $3.9M | $3.8M | $4.9M | $4.7M | $3.9M | |||||
| Operating Lease Liability Noncurrent | $56.3M | $58.1M | $59.9M | $55.8M | $57.0M | $58.2M | $52.7M | $53.8M | $52.0M | $3.0M | $3.5M | $3.9M | $4.8M | $5.2M | |||||
| Operating Lease Liability Current | $6.9M | $6.3M | $5.0M | $3.9M | $3.6M | $3.3M | $4.4M | $4.2M | $3.8M | $1.8M | $1.7M | $1.7M | $1.6M | $1.6M | |||||
| Liabilities Current | $29.2M | $31.3M | $29.8M | $28.7M | $38.6M | $31.5M | $33.2M | $35.1M | $14.0M | $16.6M | $17.2M | $18.5M | $22.9M | $20.6M | |||||
| Liabilities And Stockholders Equity | $262.2M | $298.6M | $332.7M | $348.0M | $374.9M | $240.8M | $291.4M | $316.9M | $173.6M | $165.5M | $152.4M | $168.2M | $204.9M | $130.0M | |||||
| Liabilities | $118.2M | $121.8M | $122.5M | $118.9M | $119.7M | $117.9M | $122.4M | $126.3M | $95.6M | $48.8M | $20.8M | $22.5M | $30.8M | $30.6M | |||||
| Deposits Assets Noncurrent | $288.0K | $1.8M | $1.8M | $1.8M | $1.7M | $1.6M | $1.6M | $1.6M | $706.0K | $779.0K | $166.0K | $166.0K | $166.0K | $166.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$24.6M | $7.2M | -$24.4M | -$20.6M | $86.7M | ||||||||||||||
| Assets Current | $188.2M | $221.1M | $254.8M | $274.1M | $299.5M | $164.7M | $217.6M | $242.2M | $100.9M | $141.2M | $129.4M | $145.7M | $187.0M | $110.1M | |||||
| Assets | $262.2M | $298.6M | $332.7M | $348.0M | $374.9M | $240.8M | $291.4M | $316.9M | $173.6M | $165.5M | $152.4M | $168.2M | $204.9M | $130.0M | |||||
| Additional Paid In Capital Common Stock | $625.9M | $622.9M | $619.4M | $568.4M | $564.6M | $400.7M | $396.9M | $395.6M | $259.0M | $256.3M | $255.1M | $254.0M | $252.0M | $2.1M | |||||
| Accrued Liabilities And Other Liabilities | $10.8M | $12.8M | $9.6M | $11.2M | $10.8M | $8.8M | $9.3M | $8.3M | $7.4M | $6.2M | $4.2M | $3.0M | $4.3M | $3.7M | |||||
| Accounts Payable Current | $6.4M | $4.5M | $5.0M | $3.6M | $3.1M | $2.1M | $3.2M | $3.4M | $2.8M | $2.7M | $3.1M | $2.9M | $5.1M | $3.5M | |||||
| Other Liabilities Noncurrent | $278.0K | $113.0K | $124.0K | $146.0K | $12.0K | $24.0K | $36.0K | $97.0K | $97.0K | $97.0K | $236.0K | $238.0K | |||||||
| Long Term Debt Noncurrent | $32.4M | $32.3M | $32.2M | $30.6M | $20.1M | $23.4M | $28.8M | $29.7M | $29.5M | $29.1M | |||||||||
| Marketable Securities Current | $14.9M | $48.7M | $97.6M | $138.0M | $55.5M | $22.3M | $60.2M | ||||||||||||
| Accretion Of Marketable Securities | -$1.3M | -$453.0K | |||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Long Term Debt Current | $10.3M | $6.8M | $1.1M | ||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $2.0K | -$4.0K | -$4.0K | ||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $11.7M | $9.5M | $5.2M | $4.6M | $2.5M | $515.0K |
| Payments To Acquire Property Plant And Equipment | $4.4M | $3.8M | $3.1M | $4.2M | $9.9M | $4.2M |
| Net Cash Provided By Used In Operating Activities | -$135.3M | -$110.8M | -$61.4M | -$66.5M | -$48.7M | -$3.0M |
| Net Cash Provided By Used In Investing Activities | $109.4M | -$52.6M | -$60.8M | -$4.2M | -$9.9M | -$4.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $525.0K | $538.0K | -$985.0K | $410.0K | $2.6M | $1.2M |
| Increase Decrease In Operating Lease Liability | $2.9M | $1.9M | $935.0K | -$2.0M | -$9.0K | $442.0K |
| Increase Decrease In Contract With Customer Liability | -$10.3M | -$2.8M | $11.9M | -$9.0M | -$6.5M | $19.4M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$7.2M | $4.5M | $3.9M | $732.0K | $3.2M | $1.6M |
| Increase Decrease In Accounts Payable | -$3.0M | $2.0M | -$52.0K | $528.0K | $10.0K | $1.1M |
| Net Cash Provided By Used In Financing Activities | -$336.0K | $208.8M | $135.4M | $29.4M | $189.7M | $288.0K |
| Proceeds From Stock Options Exercised | $1.7M | $711.0K | $133.0K | $291.0K | $288.0K | |
| Proceeds From Issuance Of Common Stock | $33.1M | $42.4M | $193.0K | |||
| Proceeds From Issuance Of Warrants | $158.3M | $92.3M | ||||
| Payments To Acquire Marketable Securities | $87.5M | $241.4M | $77.6M | |||
| Proceeds From Sale And Maturity Of Marketable Securities | $201.3M | $192.7M | $20.0M | |||
| Proceeds From Issuance Of Convertible Preferred Stock | $99.7M | |||||
| Increase Decrease In Prepaid Rent |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $3.4M | $2.0M | $1.1M | $984.0K | $344.0K |
| Payments To Acquire Property Plant And Equipment | $1.5M | $705.0K | $838.0K | $531.0K | $3.0M |
| Net Cash Provided By Used In Operating Activities | -$37.6M | -$29.3M | -$23.6M | -$20.1M | -$10.0M |
| Net Cash Provided By Used In Investing Activities | $13.5M | $36.2M | -$838.0K | -$531.0K | -$3.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $524.0K | -$255.0K | $1.2M | $662.0K | $718.0K |
| Increase Decrease In Operating Lease Liability | $1.2M | $214.0K | -$62.0K | -$31.0K | $56.0K |
| Increase Decrease In Contract With Customer Liability | -$2.2M | -$566.0K | -$3.9M | -$2.0M | -$1.3M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$5.4M | -$1.6M | $737.0K | -$2.8M | -$1.1M |
| Increase Decrease In Accounts Payable | $558.0K | -$410.0K | $495.0K | $824.0K | $162.0K |
| Net Cash Provided By Used In Financing Activities | -$525.0K | $258.0K | $88.0K | $99.6M | |
| Proceeds From Stock Options Exercised | $258.0K | $88.0K | $108.0K | ||
| Proceeds From Issuance Of Common Stock | |||||
| Proceeds From Issuance Of Warrants | |||||
| Payments To Acquire Marketable Securities | $60.9M | $8.8M | |||
| Proceeds From Sale And Maturity Of Marketable Securities | $76.0M | $45.6M | |||
| Proceeds From Issuance Of Convertible Preferred Stock | $0.00 | $99.7M | |||
| Increase Decrease In Prepaid Rent | $1.4M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.00 | -$1.14 | -$1.36 | -$2.75 | -$4.17 | -$28.52 |
| Weighted Average Number Of Shares Outstanding Basic | 129.8M | 112.0M | 65.6M | 24.0M | 11.7M | |
| Weighted Average Number Of Diluted Shares Outstanding | 129.8M | 112.0M | 65.6M | 24.0M | 11.7M | |
| Earnings Per Share Basic | $-1.00 | $-1.14 | $-1.36 | $-2.75 | $-4.17 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 7.1M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 11.7M | 916.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.28 | -$0.28 | -$0.26 | -$0.25 | -$0.28 | -$0.32 | -$0.24 | -$0.51 | -$0.93 | -$0.67 | -$0.63 | -$0.67 | -$0.80 | -$7.69 | -$6.49 | -$7.16 | -$6.18 | |
| Weighted Average Number Of Shares Outstanding Basic | 129.8M | 129.7M | 129.7M | 118.7M | 113.4M | 94.9M | 94.8M | 47.2M | 24.2M | 24.1M | 24.1M | 24.0M | 19.9M | 1.4M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 129.8M | 129.7M | 129.7M | 118.7M | 113.4M | 94.9M | 94.8M | 47.2M | 24.2M | 24.1M | 24.1M | 24.0M | 19.9M | 1.4M | ||||
| Earnings Per Share Basic | $-0.28 | $-0.28 | $-0.26 | $-0.25 | $-0.28 | $-0.32 | $-0.24 | $-0.51 | $-0.93 | $-0.67 | $-0.63 | $-0.67 | $-0.80 | $-7.69 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 24.0M | 19.9M | 1.4M | 1.2M | 1.0M | 908.6K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.7M | $9.5M | $5.2M | $4.6M | $2.5M | $515.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.7M | $711.0K | $133.0K | $291.0K | $288.0K | |
| Interest And Other Income | $8.8M | $12.1M | $8.0M | $1.6M | $16.0K | |
| Depreciation | $2.9M | $4.1M | $5.4M | $5.1M | $3.3M | $1.2M |
| Capital Expenditures Incurred But Not Yet Paid | $7.0K | $84.0K | $301.0K | $444.0K | $828.0K | $1.3M |
| Stock Issued During Period Value New Issues | $33.1M | $42.4M | $193.0K | $89.6M | ||
| Interest Paid Net | $2.3M | $2.9M | $3.0M | $660.0K | ||
| Adjustments To Additional Paid In Capital Warrant Issued | $158.1M | $92.3M | ||||
| Interest And Other Income Loss | $16.0K | $106.0K | ||||
| Conversion Of Stock Amount Converted1 | $14.8M | $159.4M | ||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $264.0K | $333.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.0M | $3.3M | $3.4M | $2.5M | $2.3M | $2.0M | $1.3M | $1.2M | $1.1M | $1.2M | $1.0M | $984.0K | $885.0K | $503.0K | $344.0K | $128.0K | $126.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.2M | $183.0K | $258.0K | $9.0K | $682.0K | $5.0K | $31.0K | $88.0K | $63.0K | $108.0K | $1.0K | $26.0K | |||||
| Interest And Other Income | $2.0M | $2.4M | $2.8M | $3.7M | $3.4M | $2.2M | $2.7M | $1.5M | $1.1M | $534.0K | $149.0K | $7.0K | $3.0K | $5.0K | |||
| Depreciation | $678.0K | $1.3M | $1.5M | $1.2M | $469.0K | ||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $339.0K | $309.0K | $24.0K | $416.0K | $1.8M | ||||||||||||
| Stock Issued During Period Value New Issues | $33.1M | $42.4M | $89.6M | ||||||||||||||
| Interest Paid Net | $569.0K | $758.0K | $743.0K | ||||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $128.3M | $92.3M | |||||||||||||||
| Interest And Other Income Loss | $7.0K | $3.0K | $6.0K | $1.0K | |||||||||||||
| Conversion Of Stock Amount Converted1 | |||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $191.0K |
Most recent annual filing with the SEC: March 4, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.